Home LiteratureArticle Details
PMID: 8948562 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

The pathophysiology and genetics of congenital lipoid adrenal hyperplasia.

The New England journal of medicine ·Vol. 335 ·No. 25 ·1996-12-19 ·Pages 1870-8

Bose HS, Sugawara T, Strauss JF, Miller WL, International Congenital Lipoid Adrenal Hyperplasia Consortium

Abstract

Congenital lipoid adrenal hyperplasia results in severe impairment of steroid biosynthesis in the adrenal glands and gonads that is manifested both in utero and postnatally. We recently found mutations in the gene for the steroidogenic acute regulatory protein in four patients with this syndrome, but it was not clear whether all patients have such mutations or why there is substantial clinical variation in these patients. We directly sequenced the gene for steroidogenic acute regulatory protein in 15 patients with congenital lipoid adrenal hyperplasia from 10 countries. Identified mutations were confirmed and recreated in expression vectors, transfected into cultured cells, and assayed for the presence and activity of steroidogenic acute regulatory protein. Fifteen different mutations in the gene for steroidogenic acute regulatory protein were found in 14 patients; the mutation Gln258Stop was found in 80 percent of affected alleles from Japanese and Korean patients, and the mutation Arg182Leu was found in 78 percent of affected alleles from Palestinian patients. We developed diagnostic tests for these and eight other mutations. Thirteen of the 15 mutations were in exons 5, 6, or 7, and all rendered the steroidogenic acute regulatory protein inactive in functional assays. Some mutants with amino acid replacements were capable of normal mitochondrial processing, indicating that the activity of steroidogenic acute regulatory protein is not associated with its translocation into mitochondria. Steroidogenic cells lacking the protein retained low levels of steroidogenesis. This explains the secretion of some steroid hormones by the ovaries after puberty before affected cells accumulate large amounts of cholesterol esters. The congenital lipoid adrenal hyperplasia phenotype is the result of two separate events, an initial genetic loss of steroidogenesis that is dependent on steroidogenic acute regulatory protein and a subsequent loss of steroidogenesis that is independent of the protein due to cellular damage from accumulated cholesterol esters.

MeSH Terms
Adrenal Glands/cytology,physiopathology Adrenal Hyperplasia, Congenital/diagnosis,genetics,physiopathology Female Frameshift Mutation Genetic Testing Humans Infant Infant, Newborn Male Mutation Phenotype Phosphoproteins/genetics
Chemicals
Phosphoproteins steroidogenic acute regulatory protein
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Bose H S
Department of Pediatrics, University of California at San Francisco, 94143-0978, USA.
Sugawara T
Strauss J F
Miller W L
International Congenital Lipoid Adrenal Hyperplasia Consortium
Investigators
11 investigators, click to expand
Fujieda K
Ben-Neriah Z
Rösler A
Müller J
Schwartz M
Skakkebaeck N E
Nawas M N
Papadimitriou A
Winter J S
Cowell C T
Warne G
Article Info
Journal
The New England journal of medicine
Abbr.
N Engl J Med
ISSN
0028-4793
Published
1996-12-19
Pages
1870-8
Language
English
Region
United States
NLM ID
0255562
Subset
IM
Grants
NIDDK NIH HHS · DK37922 · United States
NIDDK NIH HHS · DK42154 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com